✦ LIBER ✦

New Alzheimer's endpoints?

✍ Scribed by Aldridge, Susan

Book ID: 109903265
Publisher: Nature Publishing Group
Year: 2008
Tongue: English
Weight: 70 KB
Volume: 26
Category: Article
ISSN: 1087-0156
DOI: 10.1038/nbt0508-482a

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

FDA and surrogate endpoints in Alzheimer

FDA and surrogate endpoints in Alzheimer's disease

✍ Osborne, Randy 📂 Article 📅 2008 🏛 Nature Publishing Group 🌐 English ⚖ 56 KB

Biomarkers in Alzheimer's Disease : Not

Biomarkers in Alzheimer's Disease : Not Yet Surrogate Endpoints

✍ N Coley; S Andrieu; J Delrieu; T. Voisin; B. Vellas 📂 Article 📅 2009 🏛 John Wiley and Sons 🌐 English ⚖ 98 KB

Alzheimer's … Our New Cancer?

✍ Allan Vann 📂 Article 📅 2011 🏛 John Wiley and Sons 🌐 English ⚖ 42 KB

News Brief: Targeting Alzheimer's

✍ Nathan Seppa 📂 Article 📅 2009 🏛 Society for Science & the Public 🌐 English ⚖ 466 KB

NICE news for Alzheimer's

✍ Andrew Chidgey 📂 Article 📅 2010 🏛 Wiley (John Wiley & Sons) 🌐 English ⚖ 40 KB

Grasping premanifest Huntington's diseas

Grasping premanifest Huntington's disease – shaping new endpoints for new trials

✍ Ralf Reilmann; Stefan Bohlen; Thomas Klopstock; Andreas Bender; Adolf Weindl; Ph 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 English ⚖ 958 KB

## Abstract Future clinical trials in subjects with premanifest Huntington's disease (preHD) may depend on the availability of biomarkers. It was previously shown in symptomatic HD that, the grip force variability coefficient‐of‐variation (GFV‐C) in a grasping paradigm was correlated to the Unified